🇺🇸 Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid in United States

Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid in United States?

University of California, San Diego is the originator. The local marketing authorisation holder may differ — check the official source linked above.